A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers.

Saved in:
Bibliographic Details
Title: A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers.
Authors: Attie KM; Acceleron Pharma Inc, Cambridge, Massachusetts., Allison MJ, McClure T, Boyd IE, Wilson DM, Pearsall AE, Sherman ML
Source: American journal of hematology [Am J Hematol] 2014 Jul; Vol. 89 (7), pp. 766-70. Date of Electronic Publication: 2014 Apr 26.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1096-8652
DOI:10.1002/ajh.23732